French senate rejects 3% levy and higher pharmacoeconomic costs as it OKs financing bill
This article was originally published in Scrip
The French senate has approved the social security financing bill (PLFSS) for 2012, complete with a number of changes including a widening of the tax on pharmaceutical industry promotion and the establishment of a new independent fund to collect industry taxes and fees.
You may also be interested in...
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.
As arguments rage over whether the UK regulator has rushed its assessment of the Pfizer/BioNTech vaccine, the European Medicines Agency explains why its conditional marketing authorization approach is taking a little longer.
The UK has used a special legislative process to temporarily authorize the use of the BNT-162b2 vaccine, with the first 800,000 shots expected to be delivered within days.